Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 24, 2016
[Chemotherapy and Anticancer Immune Responses]
Mamoru Harada
Journal for Immunotherapy of Cancer
|
December 13, 2024
Local cell therapy using CCL19-expressing allogeneic mesenchymal stem cells exerts robust antitumor effects by accumulating CD103<sup>+</sup> IL-12-producing dendritic cells and priming CD8<sup>+</sup> T cells without involving draining lymph nodes
Yuichi Iida, Mamoru Harada
International Journal of Clinical Oncology
|
September 5, 2003
Target molecules in specific immunotherapy against prostate cancer
Mamoru Harada, Masanori Noguchi, Kyogo Itoh
Molecular Cancer
|
September 18, 2014
Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system
Nanae Harashima, Takafumi Minami, Hirotsugu Uemura, et al.
Microbiology and Immunology
|
November 15, 2023
Modulatory effects of supplementation of Lentinula edodes mycelia extract and l-arginine on the therapeutic efficacy of immunogenic chemotherapy in colon cancer-bearing mice
Takahito Taniura, Kazunari Ishitobi, Masaaki Hidaka, et al.
Oncotarget
|
October 28, 2015
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
Yoko Hari, Nanae Harashima, Yoshitsugu Tajima, et al.
Oncology Reports
|
February 3, 2007
Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients
Mamoru Harada, Yuki Ishihara, Kyogo Itoh, et al.
International Journal of Oncology
|
April 16, 2016
Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells
Takeharu Ogura, Yoshiyuki Tanaka, Hiroki Tamaki, et al.
Oncotarget
|
May 6, 2017
HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression
Nanae Harashima, Keizo Takenaga, Miho Akimoto, et al.
Cancer Science
|
July 5, 2003
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patients
Kazuhiko Kobayashi, Masanori Noguchi, Kyogo Itoh, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 24, 2016
[Chemotherapy and Anticancer Immune Responses]
Mamoru Harada
Journal for Immunotherapy of Cancer
|
December 13, 2024
Local cell therapy using CCL19-expressing allogeneic mesenchymal stem cells exerts robust antitumor effects by accumulating CD103<sup>+</sup> IL-12-producing dendritic cells and priming CD8<sup>+</sup> T cells without involving draining lymph nodes
Yuichi Iida, Mamoru Harada
International Journal of Clinical Oncology
|
September 5, 2003
Target molecules in specific immunotherapy against prostate cancer
Mamoru Harada, Masanori Noguchi, Kyogo Itoh
Molecular Cancer
|
September 18, 2014
Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system
Nanae Harashima, Takafumi Minami, Hirotsugu Uemura, et al.
Microbiology and Immunology
|
November 15, 2023
Modulatory effects of supplementation of Lentinula edodes mycelia extract and l-arginine on the therapeutic efficacy of immunogenic chemotherapy in colon cancer-bearing mice
Takahito Taniura, Kazunari Ishitobi, Masaaki Hidaka, et al.
Oncotarget
|
October 28, 2015
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
Yoko Hari, Nanae Harashima, Yoshitsugu Tajima, et al.
Oncology Reports
|
February 3, 2007
Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients
Mamoru Harada, Yuki Ishihara, Kyogo Itoh, et al.
International Journal of Oncology
|
April 16, 2016
Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells
Takeharu Ogura, Yoshiyuki Tanaka, Hiroki Tamaki, et al.
Oncotarget
|
May 6, 2017
HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression
Nanae Harashima, Keizo Takenaga, Miho Akimoto, et al.
Cancer Science
|
July 5, 2003
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patients
Kazuhiko Kobayashi, Masanori Noguchi, Kyogo Itoh, et al.
Page
of 11